These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 18511276)
1. Design, synthesis, and structure-activity relationships of piperidine and dehydropiperidine carboxylic acids as novel, potent dual PPARalpha/gamma agonists. Ye XY; Li YX; Farrelly D; Flynn N; Gu L; Locke KT; Lippy J; O'Malley K; Twamley C; Zhang L; Ryono DE; Zahler R; Hariharan N; Cheng PT Bioorg Med Chem Lett; 2008 Jun; 18(12):3545-50. PubMed ID: 18511276 [TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of novel oxazole containing 1,3-dioxane-2-carboxylic acid derivatives as PPAR alpha/gamma dual agonists. Pingali H; Jain M; Shah S; Makadia P; Zaware P; Goel A; Patel M; Giri S; Patel H; Patel P Bioorg Med Chem; 2008 Aug; 16(15):7117-27. PubMed ID: 18625559 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and structure-activity relationships of azole acids as novel, potent dual PPAR alpha/gamma agonists. Zhang H; Ryono DE; Devasthale P; Wang W; O'Malley K; Farrelly D; Gu L; Harrity T; Cap M; Chu C; Locke K; Zhang L; Lippy J; Kunselman L; Morgan N; Flynn N; Moore L; Hosagrahara V; Zhang L; Kadiyala P; Xu C; Doweyko AM; Bell A; Chang C; Muckelbauer J; Zahler R; Hariharan N; Cheng PT Bioorg Med Chem Lett; 2009 Mar; 19(5):1451-6. PubMed ID: 19201606 [TBL] [Abstract][Full Text] [Related]
4. Structure-based design of indole propionic acids as novel PPARalpha/gamma co-agonists. Kuhn B; Hilpert H; Benz J; Binggeli A; Grether U; Humm R; Märki HP; Meyer M; Mohr P Bioorg Med Chem Lett; 2006 Aug; 16(15):4016-20. PubMed ID: 16737814 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of azaindole-alpha-alkyloxyphenylpropionic acid analogues as PPARalpha/gamma agonists. Cai Z; Feng J; Guo Y; Li P; Shen Z; Chu F; Guo Z Bioorg Med Chem; 2006 Feb; 14(3):866-74. PubMed ID: 16249089 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of novel constrained meta-substituted phenyl propanoic acids as peroxisome proliferator-activated receptor alpha and gamma dual agonists. Suh YG; Kim NJ; Koo BW; Lee KO; Moon SH; Shin DH; Jung JW; Paek SM; Chang DJ; Li F; Kang HJ; Le TV; Chae YN; Shin CY; Kim MK; Lim JI; Ryu JS; Park HJ J Med Chem; 2008 Oct; 51(20):6318-33. PubMed ID: 18826205 [TBL] [Abstract][Full Text] [Related]
7. Novel 2,3-dihydrobenzofuran-2-carboxylic acids: highly potent and subtype-selective PPARalpha agonists with potent hypolipidemic activity. Shi GQ; Dropinski JF; Zhang Y; Santini C; Sahoo SP; Berger JP; Macnaul KL; Zhou G; Agrawal A; Alvaro R; Cai TQ; Hernandez M; Wright SD; Moller DE; Heck JV; Meinke PT J Med Chem; 2005 Aug; 48(17):5589-99. PubMed ID: 16107159 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and evaluation of 2-alkoxydihydrocinnamates as PPAR agonists. Lu Y; Guo Z; Guo Y; Feng J; Chu F Bioorg Med Chem Lett; 2006 Feb; 16(4):915-9. PubMed ID: 16300944 [TBL] [Abstract][Full Text] [Related]
9. (2R)-2-methylchromane-2-carboxylic acids: discovery of selective PPARalpha agonists as hypolipidemic agents. Koyama H; Boueres JK; Miller DJ; Berger JP; MacNaul KL; Wang PR; Ippolito MC; Wright SD; Agrawal AK; Moller DE; Sahoo SP Bioorg Med Chem Lett; 2005 Jul; 15(14):3347-51. PubMed ID: 15950464 [TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of benzoxazole containing indole analogs as peroxisome proliferator-activated receptor-γ/δ dual agonists. Gim HJ; Cheon YJ; Ryu JH; Jeon R Bioorg Med Chem Lett; 2011 May; 21(10):3057-61. PubMed ID: 21482466 [TBL] [Abstract][Full Text] [Related]
11. Discovery of tertiary aminoacids as dual PPARalpha/gamma agonists-I. Devasthale PV; Chen S; Jeon Y; Qu F; Ryono DE; Wang W; Zhang H; Cheng L; Farrelly D; Golla R; Grover G; Ma Z; Moore L; Seethala R; Sun W; Doweyko AM; Chandrasena G; Sleph P; Hariharan N; Cheng PT Bioorg Med Chem Lett; 2007 Apr; 17(8):2312-6. PubMed ID: 17292606 [TBL] [Abstract][Full Text] [Related]
12. Design and biological evaluation of novel, balanced dual PPARalpha/gamma agonists. Grether U; Bénardeau A; Benz J; Binggeli A; Blum D; Hilpert H; Kuhn B; Märki HP; Meyer M; Mohr P; Püntener K; Raab S; Ruf A; Schlatter D ChemMedChem; 2009 Jun; 4(6):951-6. PubMed ID: 19326383 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, in vitro and in silico evaluation of l-tyrosine containing PPARalpha/gamma dual agonists. Kumar R; Ramachandran U; Khanna S; Bharatam PV; Raichur S; Chakrabarti R Bioorg Med Chem; 2007 Feb; 15(3):1547-55. PubMed ID: 17166722 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation and molecular investigation of fluorinated peroxisome proliferator-activated receptors α/γ dual agonists. Fracchiolla G; Laghezza A; Piemontese L; Parente M; Lavecchia A; Pochetti G; Montanari R; Di Giovanni C; Carbonara G; Tortorella P; Novellino E; Loiodice F Bioorg Med Chem; 2012 Mar; 20(6):2141-51. PubMed ID: 22341573 [TBL] [Abstract][Full Text] [Related]
15. Modulation of PPAR subtype selectivity. Part 2: Transforming PPARα/γ dual agonist into α selective PPAR agonist through bioisosteric modification. Zaware P; Shah SR; Pingali H; Makadia P; Thube B; Pola S; Patel D; Priyadarshini P; Suthar D; Shah M; Jamili J; Sairam KV; Giri S; Patel L; Patel H; Sudani H; Patel H; Jain M; Patel P; Bahekar R Bioorg Med Chem Lett; 2011 Jan; 21(2):628-32. PubMed ID: 21195611 [TBL] [Abstract][Full Text] [Related]
16. The discovery of equipotent PPARalpha/gamma dual activators. Martres P; Faucher N; Laroze A; Pineau O; Fouchet MH; Potvain F; Grillot D; Beneton V Bioorg Med Chem Lett; 2008 Dec; 18(23):6251-4. PubMed ID: 18947994 [TBL] [Abstract][Full Text] [Related]
17. 7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists. Matin A; Gavande N; Kim MS; Yang NX; Salam NK; Hanrahan JR; Roubin RH; Hibbs DE J Med Chem; 2009 Nov; 52(21):6835-50. PubMed ID: 19807106 [TBL] [Abstract][Full Text] [Related]
18. Aleglitazar, a new, potent, and balanced dual PPARalpha/gamma agonist for the treatment of type II diabetes. Bénardeau A; Benz J; Binggeli A; Blum D; Boehringer M; Grether U; Hilpert H; Kuhn B; Märki HP; Meyer M; Püntener K; Raab S; Ruf A; Schlatter D; Mohr P Bioorg Med Chem Lett; 2009 May; 19(9):2468-73. PubMed ID: 19349176 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and evaluation of novel aryl-tetrahydropyridine PPARalpha/gamma dual agonists. Kim E; Park CS; Han T; Bae MH; Chong W; Lee CH; Shin YA; Ahn BN; Kim MK; Shin CY; Son MH; Kim JK; Moon HS; Shim HJ; Kim EJ; Kim SH; Lim JI; Lee CH Bioorg Med Chem Lett; 2008 Sep; 18(18):4993-6. PubMed ID: 18771917 [TBL] [Abstract][Full Text] [Related]
20. Pyridine-2-propanoic acids: Discovery of dual PPARalpha/gamma agonists as antidiabetic agents. Humphries PS; Almaden JV; Barnum SJ; Carlson TJ; Do QQ; Fraser JD; Hess M; Kim YH; Ogilvie KM; Sun S Bioorg Med Chem Lett; 2006 Dec; 16(23):6116-9. PubMed ID: 16979341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]